<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[NPS Pharmaceuticals Inc. | Company News & Executive Profiles - NPSP | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/nps+pharmaceuticals+inc..html?i=11]]></link>
	<description><![CDATA[Latest company news & analysis, recent events, stock quotes, earning call transcripts, with profiles and descriptions of top business executives for NPS Pharmaceuticals Inc.]]></description>
	<s:counts start="0" returned="9" found="9" />
	<language>en-us</language>
	<item>
		<title><![CDATA[NPS Pharmaceuticals Inc. Q4 2008 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-278405.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator Operator Instructions Your first question comes from the line of Marco Crosio - Jeffries. Marco Crosio - Jeffries So my first one is, can you give us a little more color on how you&#8217;re proceeding towards enrollment goals in trial completion for both 558 and GATTEX please?...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Fri, 13 Mar 2009 11:10:41 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/data.html"><![CDATA[Data]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/enrollment.html"><![CDATA[Enrollment]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/nps+pharmaceuticals+inc..html"><![CDATA[NPS Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/team+management.html"><![CDATA[Team Management]]></category>
		<category domain="http://resources.bnet.com/topic/management.html"><![CDATA[Management]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NPSP</category>
		<category domain="tickers">NPSP</category>
	</item>
	<item>
		<title><![CDATA[NPS Pharmaceuticals, Inc. Q2 2008 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-223577.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator  Operator instructions And your first question comes from the line of May-Kin Ho from Goldman Sachs. Please proceed. Davis Bu &#8211; Goldman Sachs  Hi, this is Davis Bu for May-Kin Ho. Unfortunately she had to step out. I have a couple of questions. First on...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Mon, 01 Sep 2008 22:54:11 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/nps+pharmaceuticals+inc..html"><![CDATA[NPS Pharmaceuticals Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NPSP</category>
		<category domain="tickers">NPSP</category>
	</item>
	<item>
		<title><![CDATA[Phase 3 GATTEX&#153; Results Presented at Annual Digestive Disease Week Congress Highlight Potential New Treatment in Short Bowel Syndrome]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_May_19/ai_n25433861]]></link>
		<description><![CDATA[Data Show GATTEX Reduces Parenteral Nutrition Requirements for SBS Patients  SAN DIEGO -- NPS Pharmaceuticals, Inc. (NASDAQ: NPSP) today reported the presentation of Phase 3 data at the annual Digestive Disease Week DDW Congress on GATTEX[TM] teduglutide, a novel investigational compound that may reduce dependence upon parenteral nutrition PN...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 19 May 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/nps+pharmaceuticals+inc..html"><![CDATA[NPS Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/patient.html"><![CDATA[patient]]></category>
		<category domain="http://resources.bnet.com/topic/u.s.+congress.html"><![CDATA[U.S. Congress]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NPSP</category>
		<category domain="tickers">NPSP</category>
	</item>
	<item>
		<title><![CDATA[Local earnings]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_qn4188/is_20061109/ai_n16849843]]></link>
		<description><![CDATA[Several companies, including some based in Utah or with ties to the state, reported quarterly financial results on Wednesday.   FX Energy   Salt Lake-based oil and gas company FX Energy Inc. reported a net loss of $1.7 million, or 5 cents per share, for the third quarter....]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 09 Nov 2006 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[earnings]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[FINANCE]]></category>
		<category domain="http://resources.bnet.com/topic/fx+energy+inc..html"><![CDATA[FX Energy Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/investment.html"><![CDATA[Investment]]></category>
		<category domain="http://resources.bnet.com/topic/news+corp..html"><![CDATA[News Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/nps+pharmaceuticals+inc..html"><![CDATA[NPS Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/revenue.html"><![CDATA[revenue]]></category>
		<category domain="http://resources.bnet.com/topic/stock.html"><![CDATA[stock]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">FXEN</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NWS</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NPSP</category>
		<category domain="tickers">FXEN,NWS,NPSP</category>
	</item>
	<item>
		<title><![CDATA[NPS Pharmaceuticals Closes Public Offering.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5559/is_200011/ai_n22598280]]></link>
		<description><![CDATA[SALT LAKE CITY, Nov 15, 2000    NPS Pharmaceuticals, Inc. (Nasdaq: NPSP), today announced that it  has closed a $168 million public offering of 4,000,000 shares of its  common stock at $42 per share. The underwriters also exercised their  option to purchase an additional 600,000...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 16 Nov 2000 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/nps+pharmaceuticals+inc..html"><![CDATA[NPS Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/prudential+insurance+company+of+america.html"><![CDATA[Prudential Insurance Company of America]]></category>
		<category domain="http://resources.bnet.com/topic/security.html"><![CDATA[SECURITY]]></category>
		<category domain="http://resources.bnet.com/topic/solicitation.html"><![CDATA[solicitation]]></category>
		<category domain="http://resources.bnet.com/topic/underwriter.html"><![CDATA[underwriter]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NPSP</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">PRU</category>
		<category domain="tickers">NPSP,PRU</category>
	</item>
	<item>
		<title><![CDATA[NPS Pharmaceuticals Prices Public Offering.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5559/is_200011/ai_n22597639]]></link>
		<description><![CDATA[SALT LAKE CITY, Nov 10, 2000    NPS Pharmaceuticals, Inc. (Nasdaq: NPSP), today announced the  pricing of a public offering of 4,000,000 shares of its common stock at  a price of $42.00 per share. All of the 4,000,000 shares of common stock  included in the...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 10 Nov 2000 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/benefits.html"><![CDATA[Benefits]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[HEALTHCARE]]></category>
		<category domain="http://resources.bnet.com/topic/marketing.html"><![CDATA[MARKETING]]></category>
		<category domain="http://resources.bnet.com/topic/nps+pharmaceuticals+inc..html"><![CDATA[NPS Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/pricing.html"><![CDATA[Pricing]]></category>
		<category domain="http://resources.bnet.com/topic/prudential+insurance+company+of+america.html"><![CDATA[Prudential Insurance Company of America]]></category>
		<category domain="http://resources.bnet.com/topic/software.html"><![CDATA[SOFTWARE]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NPSP</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">PRU</category>
		<category domain="tickers">NPSP,PRU</category>
	</item>
	<item>
		<title><![CDATA[NPS Pharmaceuticals Files Registration Statement for Common Stock Offering.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5559/is_200010/ai_n22593597]]></link>
		<description><![CDATA[SALT LAKE CITY, Oct 13, 2000    (Please disregard the previous press release dated September 6,  2000 concerning the Company's filing of a registration statement  for a common stock offering. The September 6, 2000 press release is  replaced in its entirety by the following information.)...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 16 Oct 2000 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/company.html"><![CDATA[Company]]></category>
		<category domain="http://resources.bnet.com/topic/nps+pharmaceuticals+inc..html"><![CDATA[NPS Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/sec.html"><![CDATA[SEC]]></category>
		<category domain="http://resources.bnet.com/topic/security.html"><![CDATA[SECURITY]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NPSP</category>
		<category domain="tickers">NPSP</category>
	</item>
	<item>
		<title><![CDATA[NPS Pharmaceuticals Files Registration Statement For Common Stock Offering.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5559/is_200009/ai_n22589570]]></link>
		<description><![CDATA[SALT LAKE CITY, Sep 06, 2000    NPS Pharmaceuticals, Inc. (Nasdaq: NPSP; Toronto: NX) announced  today that it has filed a registration statement with the Securities and  Exchange Commission relating to a proposed public offering of 3,000,000  shares of NPS common stock. The Company will...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 07 Sep 2000 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/company.html"><![CDATA[Company]]></category>
		<category domain="http://resources.bnet.com/topic/internet.html"><![CDATA[INTERNET]]></category>
		<category domain="http://resources.bnet.com/topic/nps+pharmaceuticals+inc..html"><![CDATA[NPS Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/sec.html"><![CDATA[SEC]]></category>
		<category domain="http://resources.bnet.com/topic/security.html"><![CDATA[SECURITY]]></category>
		<category domain="http://resources.bnet.com/topic/toronto.html"><![CDATA[Toronto]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NPSP</category>
		<category domain="tickers">NPSP</category>
	</item>
	<item>
		<title><![CDATA[Nps Pharmaceuticals And Kirin Pharmaceutical Division Sign Agreement For $25 Million To Collaborate On Hyperparathyroidism Drug]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_1995_July_10/ai_17211822]]></link>
		<description><![CDATA[SALT LAKE CITY,--BUSINESS WIRE--July 10, 1995--NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) announced today that it has concluded a five-year agreement with the Pharmaceutical Division of Kirin Brewery Company, Limited, of Tokyo, to develop and commercialize NPS's NorcalcinTM and other compounds for the treatment of hyperparathyroidism HPT, in Japan and certain other parts...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 10 Jul 1995 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/company.html"><![CDATA[Company]]></category>
		<category domain="http://resources.bnet.com/topic/kirin+brewery+company+ltd..html"><![CDATA[Kirin Brewery Company Ltd.]]></category>
		<category domain="http://resources.bnet.com/topic/nps+pharmaceuticals+inc..html"><![CDATA[NPS Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NPSP</category>
		<category domain="tickers">NPSP</category>
	</item>
</channel>
</rss>
